CV Sciences, Inc.

CVSI ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Oct 26, 2026 8-K
4 Sep 9, 2026 PRIMARY DOCUMENT
3 Sep 9, 2026 PRIMARY DOCUMENT
SCHEDULE 13G Sep 9, 2026
10-Q Aug 13, 2026 10-Q
8-K Aug 13, 2026 8-K
8-K Jun 4, 2026 8-K
10-Q May 15, 2026 10-Q
8-K May 14, 2026 8-K
DEF 14A Apr 15, 2026 DEF 14A
8-K Apr 10, 2026 8-K
10-K Mar 26, 2026 10-K
8-K Mar 26, 2026 8-K
8-K Mar 10, 2026 8-K
10-Q Nov 13, 2025 10-Q
8-K Nov 13, 2025 8-K
8-K Oct 10, 2025 8-K
8-K Sep 18, 2025 8-K
10-Q Aug 13, 2025 10-Q
8-K Aug 13, 2025 8-K
8-K Jun 5, 2025 8-K
10-Q May 14, 2025 10-Q
8-K May 14, 2025 8-K
DEF 14A Apr 15, 2025 DEF 14A
10-K Mar 27, 2025 10-K
← Newer Page 1 of 18 · 431 filings Older →